[1]
“Risk Analysis of AST and ALT level in Patients with Diabetes Mellitus Type 2”, Jar. Lab. Med., vol. 4, no. 1, pp. 51–55, Dec. 2023, doi: 10.31983/jlm.v4i1.8489.